Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC

Abroad (travel likely)RecruitingPHASE3

Conditions

BCLC Stage C Hepatocellular Carcinoma · Chemotherapy Effect

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Yunxiuxiu Xu, MD) · xuyxx@mail.sysu.edu.cn · 17722864609

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Hepatocellular Carcinoma · Portal Vein Tumor Thrombus · Oligometastases

Abroad (travel likely)RecruitingPHASE2

Jinan, China

SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma

Hepatocellular Carcinoma · BCLC Stage C Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE2

Jinan, China

Liver Cancer and Immunotherapy in the Liquid Biopsy Era

Hepatocellular Carcinoma · BCLC Stage B Hepatocellular Carcinoma · BCLC Stage C Hepatocellular Carcinoma

Abroad (travel likely)Recruiting

Montpellier, France

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Hepatocellular Carcinoma · Hepatocellular Cancer · Hepatocellular Carcinoma Non-resectable

Abroad (travel likely)RecruitingPHASE2

Seoul, South Korea